Measles Vaccination Cash Incentives Experimental Evidence From Nigeria
NCT04013516 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1088
Last updated 2019-07-09
Summary
IDinsight is conducting a randomized controlled trial to assess the impact of various sized cash incentives for caretakers of infants that require a 9-month measles vaccination on the completion rate for the vaccine in Nigeria. The purpose of the experiment is to help New Incentives (NI) determine the optimal size of the incentive as they scale to the North West region of Nigeria.
Conditions
Interventions
- BEHAVIORAL
-
Cash Incentive
During the phone call, New Incentives' team member promised a greater cash payment from New Incentives' staff members at primary health care facilities when infants enrolled in the program and received their measles vaccination.
- BEHAVIORAL
-
Call
A New Incentives' team member reminded caregivers of their child's measles immunization date and the total amount of incentive they would receive once their child was vaccinated. If the caregiver could not be reached on the first attempt, the team made additional attempts at different times of the day on five different days across two weeks (up to 10 attempts were made per caregiver).
Sponsors & Collaborators
-
GiveWell
collaborator OTHER -
IDinsight
lead OTHER
Principal Investigators
-
Alison Connor · IDinsight
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 9 Months
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-05-12
- Primary Completion
- 2017-09-11
- Completion
- 2017-09-11
Countries
- Nigeria
Study Locations
More Related Trials
-
Additional Measles Vaccine at 4 Months of Age
NCT01486355 ·Status: UNKNOWN ·Phase: PHASE4
-
Trial of Additional Measles Vaccine to Reduce Child Mortality
NCT01644721 ·Status: COMPLETED ·Phase: PHASE4
-
Non-Specific Effects of Standard Titre Measles Vaccination
NCT00168662 ·Status: COMPLETED ·Phase: PHASE4
-
Measles Vaccine: Is There a Protective Role in COVID 19 Pandemic?
NCT04445610 ·Status: UNKNOWN
-
Measles Vaccine in HCW
NCT04357028 ·Status: SUSPENDED ·Phase: PHASE3
-
Vaccine Campaign Effects on General Hospital Admissions and Mortality Among Children
NCT03460002 ·Status: COMPLETED ·Phase: PHASE4
-
Healthy, Immunized Communities Study
NCT03854734 ·Status: COMPLETED ·Phase: NA
-
Participant Centered Active Surveillance for Adverse Event Following Measles Immunization in Gedeo Zone, Ethiopia, 2022. A Multi-center Open-label Randomized Control Trial
NCT05803538 ·Status: UNKNOWN ·Phase: NA
-
Testing the Use of Prompts to Increase Adolescent Immunization Rates
NCT01984125 ·Status: COMPLETED ·Phase: NA
-
mHealth-Assisted Conditional Cash Transfers to Improve Timeliness of Vaccinations (D0271)
NCT03252288 ·Status: COMPLETED ·Phase: NA
-
Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children
NCT05758532 ·Status: RECRUITING ·Phase: PHASE4
-
A Second Dose of Measles Vaccine (MV) in the Second Year of Life
NCT02943681 ·Status: COMPLETED ·Phase: NA
-
Improving Uptake of Pediatric Vaccines Through Religious Conferences and Vaccines-in-a-van in Aceh, Indonesia
NCT06160999 ·Status: COMPLETED ·Phase: NA
-
mHealth to Increase Measles Immunization - a Randomized Controlled Trial in Guinea-Bissau
NCT02662595 ·Status: UNKNOWN ·Phase: NA
-
Trial of Additional Measles Vaccine to Reduce Child Mortality. Burkina Faso.
NCT01668745 ·Status: COMPLETED ·Phase: PHASE4
-
Intervention to Promote Childhood Vaccinations and Influence Vaccination Attitudes
NCT05425823 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial to Assess the Safety of a Measles Vaccine (Dry Powder) Administered by Two Different Devices
NCT01557699 ·Status: COMPLETED ·Phase: PHASE1
-
Missed Opportunities for Vaccine Equity
NCT04834960 ·Status: COMPLETED ·Phase: NA
-
Immunology of Non-specific Effects of Vaccine
NCT00168545 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda
NCT04177485 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate Safety, Dose Response and Immunogenicity of the Measles Vaccine MVA mBN85B in Healthy Children Aged 6 Months to 6 Years
NCT00891007 ·Status: COMPLETED ·Phase: PHASE2
-
Prophylactic Antibiotics in Measles
NCT00168532 ·Status: COMPLETED ·Phase: PHASE3
-
The Interaction Between Measles and DTP Vaccination
NCT02710045 ·Status: COMPLETED ·Phase: NA
-
Earlier Prime-BOOST Schedule to Improve MEasles Protection in High Burden Settings
NCT06667206 ·Status: RECRUITING ·Phase: PHASE2
-
The Next Generation Vaccine Card: Innovative Technology to Improve Vaccine Equity in Rural and Urban Settings in East Africa
NCT06470919 ·Status: COMPLETED ·Phase: NA